SLC39A14

Chr 8ADAR

solute carrier family 39 member 14

Also known as: HCIN, HMNDYT2, LZT-Hs4, NET34, ZIP14, cig19

This gene encodes a member of the the SLC39A family of divalent metal transporters that mediates the cellular uptake of manganese, zinc, iron, and cadmium. The encoded protein contains eight transmembrane domains, a histidine-rich motif, and a metalloprotease motif, and is expressed on the plasma membrane and the endocytic vesicle membrane. It is an important transporter of nontransferrin-bound iron and a critical regulator of manganese homeostasis. Naturally occurring mutations in this gene are associated with neurodegeneration with brain iron accumulation and early-onset parkinsonism-dystonia with hypermanganesemia. [provided by RefSeq, May 2017]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAD/ARLOEUF 0.552 OMIM phenotypes
Clinical SummarySLC39A14
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.26) despite low pLI — interpret in context.
📋
ClinVar Variants
14 unique Pathogenic / Likely Pathogenic· 95 VUS of 286 total submissions
📖
GeneReview available — SLC39A14
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.55LOEUF
pLI 0.150
Z-score 2.97
OE 0.26 (0.140.55)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.92Z-score
OE missense 0.68 (0.600.77)
194 obs / 285.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.26 (0.140.55)
00.351.4
Missense OE?0.68 (0.600.77)
00.61.4
Synonymous OE?0.93
01.21.6
LoF obs/exp: 5 / 19.0Missense obs/exp: 194 / 285.1Syn Z: 0.62
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSLC39A14-related early onset dystonia parkinsonismLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7229th %ile
GOF
0.75top 25%
LOF
0.2969th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

286 submitted variants in ClinVar

Classification Summary

Pathogenic9
Likely Pathogenic5
VUS95
Likely Benign116
Benign40
Conflicting6
9
Pathogenic
5
Likely Pathogenic
95
VUS
116
Likely Benign
40
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
5
0
0
9
Likely Pathogenic
2
2
1
0
5
VUS
5
84
4
2
95
Likely Benign
0
8
35
73
116
Benign
0
3
28
9
40
Conflicting
6
Total111026884271

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

82 pathogenic / likely-pathogenic (of 100) ClinVar copy-number / structural variants overlap SLC39A14 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SLC39A14 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →